Back
Arch Capital Group Vs. Avidity Biosciences Industry Stock Comparison
Buy
69
ACGL
Arch Capital Group
Last Price:
111.42
Seasonality Move:
4.99%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
69
Arch Capital Group (ACGL)
is a Buy
Is Arch Capital Group a Buy, Sell or Hold?
- The current Arch Capital Group [ACGL] share price is $113.07. The Score for ACGL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- ACGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $44.64. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACGL Stock Price Chart
What is Arch Capital Group's stock price today?
-
The Arch Capital Group share price today is $113.07
The current trend is moderately bullish and ACGL is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $44.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.76 | Buy |
Relative Strength Index (14 RSI): | 65.4 | Buy |
Chaikin Money Flow: | -187786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (105.16 - 113.54) | Buy |
Bollinger Bands (100): | (95.73 - 106.85) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 58.78 | Buy |
Chaikin Money Flow: | 2358339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.17 - 44.49) | Buy |
Bollinger Bands (100): | (30.01 - 45.23) | Buy |
ACGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.03 | Buy |
20-day SMA: | 111.14 | Buy |
50-day SMA: | 103.22 | Buy |
200-day SMA: | 92.87 | Buy |
8-day EMA: | 112.43 | Buy |
20-day EMA: | 110.19 | Buy |
50-day EMA: | 105.63 | Buy |
200-day EMA: | 94.96 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.71 | Buy |
20-day SMA: | 42.36 | Buy |
50-day SMA: | 43.76 | Buy |
200-day SMA: | 26.77 | Buy |
8-day EMA: | 42.29 | Buy |
20-day EMA: | 42.39 | Buy |
50-day EMA: | 41.68 | Buy |
200-day EMA: | 30.34 | Buy |
Arch Capital Group Earnings Growth & ACGL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $1.11 per share, and an increase next year of $0.04 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
Arch Capital Group Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |